Belgium's pharma hub still resilient despite US investment surge

EURACTIV - As Novartis, Eli Lilly and Johnson & Johnson pour billions into US-based pharmaceutical manufacturing, American companies are also continuing to invest in Belgium to serve the European market for advanced therapy medicinal products (ATMPs). Read more

Deloitte notes growing efforts across Europe to invest in incentives, infrastructure, and coordination